1. Győrffy, Balázs. 2023. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. In British journal of pharmacology, 181, 362-374. doi:10.1111/bph.16257. https://pubmed.ncbi.nlm.nih.gov/37783508/
2. Yang, Shuang, Peng, Li Rong, Yu, Ai Qing, Li, Jiang. 2023. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway. In Annals of hepatology, 28, 101118. doi:10.1016/j.aohep.2023.101118. https://pubmed.ncbi.nlm.nih.gov/37268061/
3. Ackermann, Karin, Neidhart, Tanja, Gerber, Jochen, Waxmann, Andrea, Pyerin, Walter. . The catalytic subunit alpha' gene of human protein kinase CK2 (CSNK2A2): genomic organization, promoter identification and determination of Ets1 as a key regulator. In Molecular and cellular biochemistry, 274, 91-101. doi:. https://pubmed.ncbi.nlm.nih.gov/16335532/
4. Hoenigsperger, Helene, Koepke, Lennart, Acharya, Dhiraj, Gack, Michaela U, Sparrer, Konstantin M J. 2023. CSNK2 suppresses autophagy by activating FLN-NHL-containing TRIM proteins. In Autophagy, 20, 994-1014. doi:10.1080/15548627.2023.2281128. https://pubmed.ncbi.nlm.nih.gov/37938186/
5. Zhang, Cong, Zeng, Cailing, Xiong, Shaoquan, Zhao, Zewei, Wu, Guoyu. 2022. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer. In Scientific reports, 12, 18688. doi:10.1038/s41598-022-23463-8. https://pubmed.ncbi.nlm.nih.gov/36333388/
6. Xu, X, Toselli, P A, Russell, L D, Seldin, D C. . Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. In Nature genetics, 23, 118-21. doi:. https://pubmed.ncbi.nlm.nih.gov/10471512/
7. Boccanegra, Brigida, Lenti, Roberta, Mantuano, Paola, Hildyard, John C W, De Luca, Annamaria. 2024. Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse. In PloS one, 19, e0310714. doi:10.1371/journal.pone.0310714. https://pubmed.ncbi.nlm.nih.gov/39535998/
智鼠故事 
